Enimmune corporation reported earnings results for the full year ended December 31, 2021. For the full year, the company reported sales was TWD 109.82 million compared to TWD 22.88 million a year ago. Net loss was TWD 47.25 million compared to TWD 74.45 million a year ago. Basic loss per share from continuing operations was TWD 0.79 compared to TWD 1.4 a year ago. Diluted loss per share from continuing operations was TWD 0.79 compared to TWD 1.4 a year ago.